Dapagliflozin in High-Risk Type 2 Diabetes Reduces Hospitalization for Heart Failure ...
Aug 1, 2019 - The only cardiovascular benefit to treatment with dapagliflozin was a reduction in the likelihood of hospitalization; 125 patients would need to be treated for 10 years to prevent one hospitalization.
American Family Physician : POEMs
https://www.aafp.org/afp/2019/0801/p184.html
Linagliptin and Glimepiride Equally Effective for Adults with Type 2 Diabetes Mellitus ...
Mar 1, 2020 - This study found that linagliptin is noninferior to glimepiride for reducing the risk of cardiovascular death, myocardial infarction, and stroke in adults with type 2 diabetes at an increased risk of cardiovascular disease.
American Family Physician : POEMs
https://www.aafp.org/afp/2020/0301/p309a.html
Statins Ineffective for Primary Prevention of Cardiovascular Disease in Patients 75 ...
Apr 1, 2019 - In this retrospective study, statin treatment in patients 75 years or older without preexisting CVD did not change the likelihood of developing CVD or reduce any-cause mortality. However, patients 75 to 84 years of age with diabetes mellitus benefitted from treatment. These results ...
American Family Physician : POEMs
https://www.aafp.org/afp/2019/0401/p461.html
navigate_before 1 navigate_next